Treatment of HAE Attacks with Anticipated Future Oral On-demand Therapies as Reported by Patients

Valerieva A

ACARE Global Angioedema Forum 2024 (GAF)

Phase 3 KONFIDENT Trial of Oral Sebetralstat for Treatment of Hereditary Angioedema Attacks: Analysis of the European and US Patient Subgroups

Zanichelli A

ACARE Global Angioedema Forum 2024 (GAF)

Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT Trial

Maurer M

ACARE Global Angioedema Forum 2024 (GAF)

Patient-Reported Benefits of Early On-demand Treatment of HAE Attacks

Guilarte M

ACARE Global Angioedema Forum 2024 (GAF)

KONFIDENT-S Interim Analysis: Sebetralstat for Hereditary Angioedema Attacks (Including Laryngeal)

Farkas H

Bradykinin Symposium 2024

Delayed On-demand Treatment of Hereditary Angioedema Attacks and Associated Barriers Reported by Italian Patients

Cancian M

Bradykinin Symposium 2024

A Specific, Sensitivity Assay Measuring Patient Sample Plasma Kallikrein Activity

Lee D

Bradykinin Symposium 2024

Pooled Sebetralstat Placebo-controlled Safety for On-demand Treatment of Hereditary Angioedema (Oral Presentation)

Aygören-Pürsün E

Bradykinin Symposium 2024

Pooled Sebetralstat Placebo-controlled Efficacy for On-demand Treatment of Hereditary Angioedema (Poster Presentation)

Aygören-Pürsün E

Bradykinin Symposium 2024

Closing Gaps in Hereditary Angioedema Management: Addressing Delays in On-Demand Treatment

Jones D, Buttgereit T, Carne E, Cohn D